News

A group of 151 experts convened to develop a set of recommendations for primary biliary cholangitis (PBC) treatment and care.

Researchers highlight progress in gut-targeted therapies for PBC

Epstein-Barr virus (EBV) infections may be linked to certain autoimmune liver diseases, such as hepatitis and PBC.

Male patients with PBC were more likely than female patients to have advanced disease, yet were less likely to receive care.

New research shows pruritus in PBC significantly increases healthcare visits and costs, highlighting the need for better symptom management.

Most people with primary biliary cholangitis (PBC) can anticipate safe and successful pregnancies, new research finds.

The GLISTEN clinical trial found that patients with PBC who take linerixibat experience less itching and fewer sleep disturbances.

A genetic variant near the ETS1 gene called rs10893900 increases risk for primary biliary cholangitis (PBC).

People with PBC who stay on treatment long enough to reach normal ALP levels face fewer liver complications and better long-term outcomes.

Rates of PBC recurrence after a liver transplant differed from country to country, suggesting that local factors play a role.